Report cover image

ISSUE 4 of 6 - In Vitro Diagnostics Business Outlook, Volume 4, Issue 4 - Focus on Histology/Cytology IVD Testing

Publisher Kalorama Information
Published Jun 01, 2025
Length 47 Pages
SKU # KLI20438787

Description

The in vitro diagnostics (IVD) sector stands as a cornerstone of modern healthcare, empowering clinicians with the tools to detect diseases, monitor health conditions, and guide precise treatment decisions.

As healthcare evolves, the IVD market is poised for transformative growth. With the rising prevalence of chronic conditions such as diabetes and cardiovascular diseases, as well as ongoing threats from infectious diseases like COVID-19 and emerging variants, the demand for innovative diagnostic solutions has never been greater.

In Vitro Diagnostics Business Outlook is a bimonthly publication, delivering six issues annually, each dedicated to a different segment of the IVD industry. It provides exclusive insights and data, including:
  • Market Data and Forecasts: Detailed growth rates, market size, and market share to identify new opportunities.
  • Comprehensive Market View: Coverage of test categories and company profiles.
  • M&A Activities: Updates on mergers, acquisitions, partnerships, and collaborations.
  • Industry & Region Watch: Tailored strategies based on regional and industry-specific trends.
  • News Analysis: In-depth reporting on significant news and events, including exclusive information not readily available elsewhere.
Please Note: Single user allows for up to 3 users for this report.

Table of Contents

47 Pages
MARKET ANALYSIS: HISTOLOGY/CYTOLOGY TESTING
OVERVIEW OF HISTOLOGY/CYTOLOGY TESTING
MARKET OUTLOOK: HISTOLOGY/CYTOLOGY
OVERVIEW OF HISTOLOGY/CYTOLOGY
Table: Histology/Cytology Diagnostic Sales, by Broad Test Category, 2025 ($ million) [Pap Tests, in situ Hybridization, Immunohistochemistry, Traditional Non-Pap Stains, HPV – Amplification/Genome]
Figure: Histology/Cytology Diagnostic Market Distribution, by Broad Test Category, 2025 (%) [Pap Tests, in situ Hybridization, Immunohistochemistry, Traditional Non-Pap Stains, HPV – Amplification/Genome]
Figure: Evolution of the Histology/Cytology Diagnostic Market, 2020-2030 ($ million) [Pap Tests, in situ Hybridization, Immunohistochemistry, Traditional Non-Pap Stains, HPV – Amplification/Genome]
REGIONAL MARKET
Table: Global Histology/Cytology Sales Distribution, by Region, 2025 (%) [North America, Europe, Asia Pacific, RoW]
COMPANY BRIEFS
Agilent
Danaher
Hologic
Roche
EXECUTIVE NEWS BRIEFING
BRIEFINGS
Visby Medical Raises $55 Million
GeneCentric Raises $8 Million in Series C Round
Aptitude Medical Systems Secures $9 Million in BARDA Funding
Aptitude Medical Systems Secures $8.25 Million in BARDA Funding
South Korea’s QuantaMatrix Awarded $2.9 Million
Cyted Health Raises $44 Million in Series B Financing Round
Monod Bio Reaps $1.5 Million Gates Foundation Grant
Octave Bioscience Closes $35 Million in Series C Financing
FINANCIAL HIGHLIGHTS: ABBOTT, HORIBA
ABBOTT LEANS ON DIABETES CARE SEGMENT FOR GROWTH IN 2025
Diabetes Care – U.S. Market Performance
Diabetes Care – International Market Performance
Diagnostic Snapshot
Table: Diagnostic Sales, Abbott Laboratories, H1 2024 and 2025 ($ million)
Abbott: Total Company Performance
Table: Total Sales, Abbott Laboratories, H1 2024 and 2025 ($ million)
HORIBA REPORTED YEAR-OVER-YEAR GROWTH IN H1 ’25 OF 4.4%, INCREASING BY 6.2 BILLION YEN; EXPECTS 5.6% GROWTH FULL YEAR
Figure: Horiba Sales by Business Segment, H1 2024 vs H1 2025 (million Yen) [Energy & Environment, Bio & Healthcare, Materials & Semiconductor]
Figure: Horiba H1 2024 & H1 2025 Net Sales, Operating Income, Operating Income Ratio (million Yen)
Table: Horiba H1 2024 & H1 2025 Geographic Market Performance (million Yen) [Japan, Asia, Americas, Europe, Total]
Figure: Horiba H1 2024/2025 Bio & Healthcare Division, Geographic Market Performance (million Yen) [Japan, Asia, Americas, Europe]
DIAGNOSTIC MARKET MERGERS, ACQUISITIONS, AND PARTNERSHIP DEALS
PARTNERSHIPS AND COLLABORATIONS
MERGERS AND ACQUISITIONS
Table: Recent Diagnostic Market Mergers, Acquisitions, and Partnership Deals
INDUSTRY WATCH
INDUSTRY WATCH COVID-19/FLU UPDATE
REGION WATCH
POLAND
Figure: Poland Population Distribution, 2000 through 2100
Poland: Healthcare Investment and IVD Market Overview
IVD Market in Poland
Figure: Poland - Market Distribution of Broad IVD Segments, 2025 (%) [Immunoassays, Microbiology/Virology, Point-of-Care, Histology/Cytology, Chemistry/Hematology/Coagulation, Other Segments]
BROAD-BASED COMPANY ANNOUNCEMENTS
ANNOUNCEMENTS
Roche Secures CE-IVDR for its HER2 CDx Assay
QIAGEN Launches QIAstat -Dx Rise
Agilent Receives FDA Approval
Pearl Diagnostics Receives FDA Clearance for New Assay
Thermo Fisher Captures FDA Approval for NGS-based Companion Diagnostic
Hardy Diagnostics Captures FDA Clearance for NG Test
Diasorin Captures FDA Clearance for Multiplex Molecular Panel
Waters and BD Biosciences & Diagnostics Combine
Thermo Fisher Gains NGS Assay Approval
EpiCypher Launches Single-Molecule Genomics Assay
BioMérieux Secures FDA and CLIA-waiver Clearance
Biocartis Captures FDA Approval for CDx

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us